EXCLUSIVE — The Trump administration is moving to reduce reliance on animal testing for medical research as part of its broader effort to modernize federal biomedical research agencies.

Several agencies within the Department of Health and Human Services announced new programs on Monday to transition away from animal use in drug testing and medical research and toward biotechnologies, including human organoids, artificial intelligence, and computational modeling.